TABLE 3.

Multivariate Cox Regression Analyses for Risk of Biochemical Progression with SUV-Based Variable

Variable	Model 1		Model 2		Model 3
Variable	HR	P	HR	P	HR	P
Initial clinical T stage
T2		0.09		0.15		0.08
T3a	0.42 (0.04–4.78)	0.48	0.38 (0.03–4.35)	0.43	0.39 (0.03–4.54)	0.46
T3b	2.98 (0.66–13.51)	0.16	2.39 (0.0–11.28)	0.27	2.95 (0.65–13.48)	0.16
SUV_max before treatment	1.01 (0.99–1.04)	0.35	—		—
SUV_max after treatment	—	—	1.02 (1.00–1.04)	0.02^*	—
SUV_max decline percentage	—	—	—	—	1.00 (1.00–1.00)	0.46
pCR or MRD (yes vs. no)	0.11 (0.01–0.89)	0.04^*	0.12 (0.02–0.98)	0.048^*	0.10 (0.01–0.80)	0.03^*